Posts by: David Melamed, PhD

David Melamed, PhD

David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.

November 10, 2020November 10, 2020

Israel Grants Owlytics $1.3M to Develop Wearable AI Device to Improve MS Care

News

The Israeli Innovation Authority has awarded Owlytics Healthcare a $1.3-million grant to support the company’s development of wearable artificial intelligence (AI) technology that has the potential to improve multiple sclerosis ... Read more

September 28, 2020September 28, 2020

MS Patients Report Moderate Health-related Quality of Life, Literature Review Finds

News

Patients with multiple sclerosis (MS) report moderate scores in mental and physical health, as measured by three, well-established quality-of-life scales, according to an analysis of published literature. The study, “Global, ... Read more

July 16, 2020July 16, 2020

MSAA Opens ‘COVID-19 and MS Pathfinder’ Online Informative Platform

Covid-19, News

The Multiple Sclerosis Association of America (MSAA) teamed with Wondros, a creative production company, to launch COVID-19 and MS Pathfinder, an online platform offering the multiple sclerosis (MS) community accurate and regularly updated information ... Read more

July 6, 2020July 6, 2020

Higher BMI as Teenagers Raises Risk of MS for Men, Study Finds

News

Young men, ages 16 to 20, with a higher the body mass index (BMI) are at greater their risk of being diagnosed with multiple sclerosis (MS) later in life, regardless ... Read more

July 2, 2020July 2, 2020

PROTXX, University of Alberta Collaborate to Develop Remote Healthcare Platform for MS Patients

News

The University of Alberta and PROTXX are collaborating to develop wearable sensors for people with multiple sclerosis (MS) and advance a remote healthcare platform that facilitates personalized care and reduces frequency of ... Read more

June 26, 2020June 26, 2020

Online Resource Center Informs MS Patients About Treatments, Adherence

News

MyHealthTeams and EMD Serono have teamed up to launch the Treatment and Adherence Resource Center, a new informational tool within the MyMSTeam social network for people living with multiple sclerosis (MS). ... Read more

June 25, 2020June 25, 2020

Walking Patterns of MS Patients Studied to Reduce Risk of Falling

News

People with multiple sclerosis (MS) exert increased caution with their walking pattern and take smaller steps overall, a study shows. These findings could contribute to the development of better walking ... Read more

June 8, 2020June 8, 2020

Andrographolide Shows Promising Results for Non-active PMS Patients in Trial

News

Andrographolide, an herbal compound with anti-inflammatory and neuroprotective properties, is able to slow brain atrophy and progression of disability in people with non-active progressive multiple sclerosis (PMS), according to results ... Read more

April 24, 2020October 14, 2020

MS Patients Invited to Join Dutch Survey Study of Working Life

News

Researchers at Vrije University Amsterdam in the Netherlands are inviting employed people with multiple sclerosis (MS) to take part in an online survey, in the form of three questionnaires spaced over two months, ... Read more

April 2, 2020April 2, 2020

Diets of MS Patients in Spain Seen to Favor Fats, Proteins and Inflammation

News

A study from Spain found the diet of multiple sclerosis (MS) patients to contain more fat and protein, and fewer carbohydrates, than recommended, which was linked to abdominal weight gain and ... Read more

March 23, 2020May 12, 2020

Phase 2 Trial of Progressive MS Treatment Postponed Due to COVID-19

Covid-19, News

A planned Phase 2 clinical trial of a potential treatment for progressive multiple sclerosis has been postponed to keep hospital resources open to treat people with COVID-19 during the ongoing global ... Read more

March 18, 2020March 18, 2020

MS Patients Find Cannabis Helpful for Easing Pain, Spasticity, Study Reports

News

About 85% of people with multiple sclerosis (MS) using cannabis find it to be helpful for pain, and 79% find it eases spasticity, a new study reports. The study, “Cannabis use ... Read more

March 17, 2020March 17, 2020

Virtual Reality Test Can Detect Subtle Balance Issues in MS Patients

News

A new test involving a virtual reality simulation was able to detect balance issues in patients with multiple sclerosis (MS), potentially allowing doctors to identify whether a patient is at ... Read more

February 24, 2020February 25, 2020

MS Patients Switching from Tysabri to Other Therapies May Risk Disease Activity

News

Multiple sclerosis (MS) patients switching from Tysabri (natalizumab) to other disease-modifying therapies may have an increased risk of disease activity, though the risk is lower if the switch is limited ... Read more

Join our email list!